Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Rangering i aksjer #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Aksjekurs
$1.30
Sist synkronisert: 2023-10-13
Markedsverdi
$38.02M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Zynerba Pharmaceuticals, Inc. (ZYNE)

Kategori

Historikk for aksjesplitt for Zynerba Pharmaceuticals, Inc. (ZYNE)
Aksjen Zynerba Pharmaceuticals, Inc. (symbol: ZYNE) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 20, 2026.
Én ZYNE-aksje kjøpt før Aug 20, 2026 tilsvarer i dag 0 ZYNE-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter